Miami Cardiac & Vascular Institute Completes $120 Million Expansion Project
Multidisciplinary cardiovascular care facility offers world’s most advanced Cath Lab,
including the Philips Azurion Image Guided Therapy System
MIAMI, FL – March 2, 2017 — Miami Cardiac & Vascular Institute has completed its $120 million expansion project on the Baptist Hospital campus. The state-of-the-art facility includes additional space and cutting-edge technology, facilitating the creation of several new, specialized programs bringing together multidisciplinary teams of specialists to treat the cardiovascular system as a single entity.
The expansion added 60,000 square feet of new space and included 40,000 square feet of renovations, nearly doubling the size of the Institute to 150,000 square feet in order to accommodate a growing number of patients and procedures. Since it was founded in 1987, Institute physicians have pioneered less-invasive techniques to treat aneurysms, stroke and heart disease, and have been part of many groundbreaking research trials.
For 30 years, Miami Cardiac & Vascular Institute has been an integral innovation partner for Philips, a world leader in healthcare technologies, providing valuable clinical insights that have led to the development of industry-leading solutions such as the recently announced Philips Azurion Image Guided Therapy (IGT) system. The expansion includes a state-of-the-art Cath lab, representing the first North American installation of Azurion. The system is designed to anticipate what clinicians need, when they need it, to make procedures flow intuitively and support a superior patient experience.
“This expansion allows us to be at the forefront of medical innovation and provides the most current treatment options for our patients, while at the same time, prepares us to be in the position to care for health problems we haven’t even encountered yet,” said Barry T. Katzen, M.D., Chief Medical Executive and founder of the Institute. “We are now able to conduct more research, offer new services and make discoveries that could transform how cardiovascular care is delivered.”
Throughout its history, the Institute’s physicians have pioneered less-invasive techniques to treat aneurysms, stroke and heart disease, and have been part of many groundbreaking research trials. The newly expanded Institute, with its cutting-edge equipment and unique programs, allows our internationally respected physicians to continue their visionary work.
One of the first elements of the three-year project was the expansion of Baptist Hospital’s Surgery Center, which now includes six large operating rooms dedicated to neuroscience, cardiac, vascular and robotic surgery. The Institute also added four new advanced endovascular suites with enlarged gallery viewing areas for enhanced teaching and learning opportunities. “This is the centerpiece of the expansion, the Center for Advanced Endovascular Therapies,” Dr. Katzen explained. “We wanted to create an environment in which we could do any type of predominantly image-guided procedure, where physicians of different disciplines could work together to create unique solutions for patients’ problems.”
In designing interventional suites of the future, two of the new endovascular suites have glass walls and a video system that allow people to sit in a theater-style chair outside of the suite and control what they are watching using an iPad. Viewers from different disciplines or in training each can have their own unique user interface that allows them to pick and choose which parts of the procedure they want to watch, all with communication with the suites.
Additionally, the Institute makeover created the National Center for Aneurysm Therapy — the first in the world — a Center for Structural Heart Therapy, Center for Critical Limb Ischemia and an Advanced Arrhythmia Therapy Center. It is here where physicians are doing research to discover more cardiovascular disease breakthroughs.
“We are proud to open the doors of the new Miami Cardiac & Vascular Institute to our community,” said Brian E. Keeley, President and CEO of Baptist Health South Florida. “This expansion now provides even greater promise to our patients, with new state-of-the-art interventional procedure suites; an expansive, high-tech gallery for observation, diagnostics and greater teaching opportunities; and, research space for more than 120 clinical trials.”
Miami Cardiac & Vascular Institute is the largest and most comprehensive cardiovascular facility in the region, consisting of 76 doctors and 1,100 employees system-wide serving 125,000 patients every year.
“At Philips, we are committed to building a healthy society by creating solutions that are going to have a meaningful impact in improving human health, and this requires collaboration with pioneering organizations like Miami Cardiac & Vascular Institute,” said Brent Shafer, CEO of Philips North America. “The Institute’s clinical insights have been critical to the development of our Azurion technology, from understanding workflows and improving efficiencies, to understand how to improve the patient experience. Together, we are shaping the future of healthcare by making procedures safer and more efficient. This will not only help address the health issues in South Florida communities, it will allow us to apply those lessons globally to help tackle the challenges of rising healthcare costs and better access to care. Ultimately, we want to improve the patient experience and outcomes, one community at a time.”
About Miami Cardiac & Vascular Institute
Miami Cardiac & Vascular Institute is the largest and most comprehensive cardiovascular facility in the region. The team of multilingual, multidisciplinary specialists has pioneered the development of minimally invasive techniques used to treat aneurysms, blockages in veins and arteries and holes in the heart.
Miami Cardiac & Vascular Institute is part of Baptist Health South Florida, the largest healthcare organization in the region, with seven hospitals (Baptist Hospital, Baptist Children’s Hospital, Doctors Hospital, Homestead Hospital, Mariners Hospital, South Miami Hospital and West Kendall Baptist Hospital), nearly 50 outpatient and urgent care facilities, Baptist Health Medical Group, Baptist Health Quality Network and internationally renowned centers of excellence. The not-for-profit, faith-based Baptist Health has approximately 16,000 employees and 2,300 affiliated physicians. Baptist Health South Florida has been recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies. For more information, visit BaptistHealth.net and connect with us on Facebook at facebook.com/BaptistHealthSF and on Twitter and Instagram @BaptistHealthSF.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips’ health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 71,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
# # #
Miami Cardiac & Vascular Institute First in South Florida to Implant First-of-its-kind Fully Dissolving Heart Stent
Recently approved by FDA, Absorb bioresorbable vascular scaffold opens clogged arteries to restore blood flow,
then gradually dissolves in the body
Miami, FL — December 19, 2016 —The interventional cardiology team at Miami Cardiac & Vascular Institute at Baptist Hospital recently became the first in South Florida to offer patients with coronary artery disease a new treatment option that literally disappears over time.
Ramon Quesada, M.D., Ramon Quesada, M.D., Medical Director of the Structural Heart and Complex Percutaneous Coronary Intervention Programs at Miami Cardiac & Vascular Institute at Baptist Hospital, implanted a patient with the world’s first FDA-approved biodegradable heart stent or “scaffold.” The Absorb bioresorbable vascular scaffold is a major advance in the treatment of coronary artery disease, which affects 15 million people in the United States and remains a leading cause of death worldwide despite decades of therapeutic advances.
The Institute was the only South Florida medical facility to participate in the clinical trials for the new device.
While stents are traditionally made of metal, Abbott’s Absorb stent is made of a naturally dissolving material, similar to degradable sutures. Absorb disappears completely in about 3 years, after it has done its job of keeping a clogged artery open and promoting healing of the treated artery segment. By contrast, metal stents are permanent implants.
“This absorbable stent is a revolutionary advancement in the treatment of coronary artery disease,” explained Dr. Quesada, who was the principal investigator for the trials at the Institute. “It benefits the patient by treating the diseased artery then gradually dissolving, leaving a healed artery that can pulse naturally, the way it was meant to function.”
Other Institute physicians who took part in the clinical trials were Marcus St. John, M.D.; Ramon Lloret, M.D.; Rajesh Dhairyawan, M.D.; Alvaro Gomez, M.D.; and Bernardo Lopez Sanabria, M.D.
To ensure optimal patient selection and implant technique, Miami Cardiac & Vascular Institute’s interventional cardiology team underwent extensive training on the new device.
Miami Cardiac & Vascular Institute is part of Baptist Health South Florida, the largest faith-based, not-for-profit healthcare organization in the region. It also includes Baptist Hospital, Baptist Children’s Hospital, South Miami Hospital, Doctors Hospital, West Kendall Baptist Hospital, Homestead Hospital, Mariners Hospital and Baptist Outpatient Services. For more information, visit BaptistHealth.net/Heart and connect with BaptistHealthSF on Facebook, Twitter and YouTube.
# # #
1 Absorb dissolves except for two pairs of tiny metallic markers that remain in the artery to enable a physician to see where the device was placed.
Stenting and Surgery Equally Safe and Effective at Lowering Long-Term Risk of Stroke, Study Finds
Stenting and surgery are equally effective at lowering the long-term risk of stroke from a narrowed carotid artery, according to results of the CREST trial that were recently published in the New England Journal of Medicine. Miami Cardiac & Vascular Institute was one of the key clinical trial sites in the United States to participate in the study – one of the largest randomized stroke prevention trials ever, in both patients who had stroke symptoms and those who hadn’t but were at risk from carotid artery narrowing.
CREST (Carotid Revascularization Endarterectomy versus Stenting Trial) conducted a study of 2,502 patients with an average age of 69 for up to 10 years at 117 centers in the U.S. and Canada. The study found the risk for stroke after either stenting or surgery (endarterectomy) was about 7 percent. The 10-year comparisons of restenosis (re-narrowing of the carotid artery) were low for both stenting and surgery – about 1 percent per year. Equal benefit was found for older and younger individuals, men and women, patients who had previously had a stroke, and those who had not.
“These long-term results of a landmark clinical trial mean that patients and physicians have a choice and the ability to optimize which treatment might be suitable for individual patients,” said Barry T. Katzen, M.D., founder and chief medical executive of Miami Cardiac & Vascular Institute, and the site principal investigator. Dr. Katzen is also a member of the CREST Interventional Management Committee.
Stroke is the fifth most common cause of death in the United States and the leading cause of disability in adults. Plaque buildup can cause narrowing and hardening of the carotid artery. This can reduce blood flow and cause clotting, which can result in a stroke. Endarterectomy is a surgical procedure performed to remove the narrowed segment of the artery, while stenting is an interventional procedure that uses a catheter to place a stent in the narrowed artery to widen it.
Despite the results of CREST, research continues to find the best way to manage stroke risk. CREST-2 was launched in December 2014 to compare stenting and surgery to medical management. Dr. Katzen also leads the interventional team at Miami Cardiac & Vascular Institute for the CREST-2 trial, which is supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health.
Miami Cardiac & Vascular Institute is part of Baptist Health South Florida, the largest faith-based, not-for-profit healthcare organization in the region. It also includes Baptist Hospital, Baptist Children’s Hospital, South Miami Hospital, Doctors Hospital, West Kendall Baptist Hospital, Homestead Hospital, Mariners Hospital and Baptist Outpatient Services. For more information, visit BaptistHealth.net/Heart and connect with BaptistHealthSF on Facebook, Twitter and YouTube.
Contact: Claudia Vigil-Perez, [email protected], 786-596-4507
Barry T. Katzen, M.D., Named Chief Medical Executive of Miami Cardiac & Vascular Institute at Baptist Health South Florida
MIAMI, FL – October 26, 2015 – Barry T. Katzen, M.D., founder of Miami Cardiac & Vascular Institute, was named chief medical executive of the Institute, which is part of Baptist Health South Florida.
With the need for significantly greater executive leadership spanning the system-wide clinical domain, Dr. Katzen becomes a full-time executive with Baptist Health. In this role, he is responsible for providing clinical leadership and expertise to the cardiovascular physicians throughout Miami Cardiac & Vascular Institute, which has more than 25 locations of integrated heart and vascular services across South Florida. In addition to his expanded leadership responsibilities, Dr. Katzen will continue to practice vascular and interventional radiology and care for patients.
“Building and maintaining a high-quality, innovative cardiovascular service line requires visionary leadership,” said Jack Ziffer, M.D., Ph.D., executive vice president and chief physician executive for Baptist Health. “Dr. Katzen’s important contributions to research and cutting-edge treatments for heart and vascular conditions, combined with his many years of success leading the Institute’s skilled physicians in a collaborative manner, have been and will continue to be extremely valuable to our organization.”
Dr. Katzen, who founded Miami Cardiac & Vascular Institute in 1987, has played a vital role in developing interventional radiology as a specialty of medicine. He has been a national site principal investigator for many clinical trials in the study of aneurysms, carotid artery disease, and peripheral vascular disease and has been involved in the development of numerous devices for less invasive vascular therapy. Dr. Katzen has been recognized globally as a leader in advancing cardiovascular medicine.
“We are fortunate to have a nationally and internationally renowned pioneer in his field as one of our physicians and leaders,” said Brian E. Keeley, president and chief executive officer of Baptist Health. “His unwavering passion and expertise will continue to pave the way for the future of world-class cardiovascular care for our community and beyond.”
Dr. Katzen is joined on the leadership team by Carol Mascioli, chief operating officer for Miami Cardiac & Vascular Institute, and Bo Boulenger, chief executive officer of Baptist Hospital, who is Baptist Health’s executive champion for the Institute. Also, Dr. Katzen will serve as the first Chairman of the Board for the Institute’s newly formed management group.
Miami Cardiac & Vascular Institute is currently undergoing a $100 million expansion on the Baptist Hospital campus that will feature the development of unique programs for aneurysms and structural heart disease.
About Baptist Health South Florida
Baptist Health is the largest healthcare organization in the region, with seven hospitals (Baptist Hospital, Baptist Children’s Hospital, Doctors Hospital, Homestead Hospital, Mariners Hospital, South Miami Hospital and West Kendall Baptist Hospital) and nearly 50 outpatient and urgent care facilities spanning three counties. The not-for-profit, faith-based Baptist Health has approximately 16,000 employees and 2,200 affiliated physicians, and also includes Baptist Health Medical Group, Baptist Outpatient Services and internationally renowned centers of excellence. Baptist Health Foundation, the organization’s fundraising arm, supports services at all hospitals and facilities. Baptist Health was listed by Fortune magazine as one of the 100 Best Companies to Work For in America (#23 in the nation) and has remained on the list for 15 years. It was also recognized as one of the World’s Most Ethical Companies for the fifth year in a row by the Ethisphere Institute.
Baptist Health integrates heart and vascular services under one name – Miami Cardiac & Vascular Institute
Baptist Health South Florida announced today it has a new name for its heart and vascular services – Miami Cardiac & Vascular Institute. Baptist Cardiac & Vascular Institute (located at Baptist Hospital), South Miami Heart Center (located at South Miami Hospital), as well as cardiovascular services at its other hospitals and outpatient centers will be re-branded with the new name.
The name change reflects the power of Baptist Health’s combined resources of experienced physicians and leading-edge treatments and technology to bring the most advanced heart and vascular care to South Florida. “A global destination like Miami deserves unparalleled cardiovascular services and breakthrough research, which Miami Cardiac & Vascular Institute offers to patients in our community and those who travel here for care,” said Brian E. Keeley, president and chief executive officer of Baptist Health.
“Miami Cardiac & Vascular Institute is on a journey that will transform it into a national leader in cardiac and vascular care. As Baptist Health continues to grow, it is essential to integrate our services to ensure seamless care for our patients across the system,” said Barry T. Katzen, M.D., founder and executive medical director of the Institute.
For more than 50 years, each of the hospitals affiliated with Baptist Health has provided excellent heart and vascular care to the community. This long history has benefited hundreds of thousands of patients with leading-edge prevention, innovative treatments and pioneering research.
“Our doctors, nurses and technologists work as a team combining their experience to provide the highest level of care and compassion for our patients and their families,” said Harry Aldrich, M.D., chief of cardiology of the former South Miami Heart Center.
“Baptist Health has a national reputation for high-quality patient care. This is an opportunity to leverage the expertise and outcomes within Baptist Health and remain the quality leader for cardiovascular services in our region,” said Jonathan Fialkow, M.D., medical director of clinical cardiology at the Institute and executive medical director of Baptist Health Quality Network.
Part of Baptist Health’s commitment to the community is a $100 million expansion project that is underway on the Baptist Hospital campus and will transform the Institute, including the development of unique programs for aneurysms and structural heart disease. The systemwide integration affords us with exciting opportunities and expands upon the Institute’s longstanding commitment to multidisciplinary cooperation that has served as a national model of success,” said Bo Boulenger, executive champion for the Institute and chief executive officer of Baptist Hospital.
As Miami Cardiac & Vascular Institute’s newly appointed chief operating officer, Carol Mascioli will oversee all cardiac and vascular services at Baptist Health hospitals and outpatient facilities.
“This is a natural step forward as we continuously strive to improve care and the overall patient experience,” said Mascioli, who brings extensive experience to her new role. Previously, Mascioli served as vice president at Baptist Hospital.
Miami Cardiac & Vascular Institute Joins WomenHeart National Hospital Alliance
Contact: Damaris Zabala, 786-596-6534, [email protected]
Branson family, lively bidding on trip to outer space boost Baptist Health charity
Contact: Melissa Lichtenheld, 305-372-1234; [email protected]; Wragg & Casas Public Relations